Results 321 to 330 of about 311,988 (356)
Some of the next articles are maybe not open access.
Progressive Systemic Sclerosis
Annals of Internal Medicine, 1978Excerpt To the editor: Data in a recent article on Sjogren's syndrome in scleroderma by Cipoletti and associates (Ann Intern Med87:535-541, 1977) apparently differ enough from ours (1) to cite us i...
openaire +2 more sources
Systemic sclerosis and multiple sclerosis
Journal of Neurology, 1999[No abstract available]
SPADARO, Antonio +3 more
openaire +2 more sources
Progressive Systemic Sclerosis
Clinics in Rheumatic Diseases, 1983To date, largely because of convenience, therapeutic trials in progressive systemic sclerosis have been few and largely short-term retrospective single institution studies. For the future, there is a pressing need to expand efforts in this area to include: controlled, prospective studies with adequate numbers of patients employing, if necessary, a ...
openaire +2 more sources
Treatment of systemic sclerosis
Current Opinion in Rheumatology, 1991Systemic sclerosis is an extremely variable disease in its manifestations and consequently, treatment needs to be individualized depending on the specific problems that each patient has. Limited scleroderma patients have a prolonged duration of Raynaud's phenomenon and puffy fingers before they develop any skin thickening, digital ulcers or ...
openaire +3 more sources
Treatment of systemic sclerosis
Current Opinion in Rheumatology, 1993Guidelines for the conduct of clinical trials in progressive systemic sclerosis have been recommended to determine drug efficacy better. To date, the results of disease-modifying drugs in scleroderma have been disappointing. The treatment of esophagitis has been revolutionized by omeprazole.
openaire +3 more sources
Epstein–Barr virus and multiple sclerosis
Nature Reviews Microbiology, 2022Samantha S Soldan, Paul M Lieberman
exaly
Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM
Nature, 2022Tobias V Lanz +2 more
exaly